Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Perimeter Solutions Sa
Perimeter Solutions Reports Fourth Quarter 2025 Financial Results
Business
Feb 26 2026
20 min read

Perimeter Solutions Reports Fourth Quarter 2025 Financial Results

news images

Full year Net Loss of $206.4M and Adjusted Net Income of $206.7M

Continued value driver execution drove full year Adjusted EBITDA of $331.7M

Full year Loss Per Diluted Share of $1.37 and Adjusted Earnings Per Diluted Share of $1.34

Specialty Products Segment acquired add-on product lines in Q4 2025, and MMT in Q1 2026

CLAYTON, Mo., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Perimeter Solutions, Inc. (NYSE: PRM) (“Perimeter,” “Perimeter Solutions,” or the “Company”), a leading provider of industrial products and services that support critical and complex customer missions across a range of niche applications, today reported financial results for its fourth quarter, and full year, ended December 31, 2025.

Full Year 2025 Results

  • Net sales increased 16% to $652.9 million, as compared to $561.0 million in the prior year.

    • Fire Safety net sales increased 12% to $489.0 million, as compared to $436.3 million in the prior year.

    • Specialty Products net sales increased 31% to $163.9 million, as compared to $124.7 million in the prior year.

  • Net loss was $206.4 million, or $1.37 loss per diluted share, as compared to a net loss of $5.9 million, or $0.04 loss per diluted share in the prior year.

  • Non-GAAP adjusted earnings per diluted share was $1.34, as compared to non-GAAP adjusted earnings per share of $1.11 in the prior year.

  • Adjusted EBITDA increased 18% to $331.7 million, as compared to $280.3 million in the prior year.

    • Fire Safety Segment Adjusted EBITDA increased 21% to $290.5 million, as compared to $240.1 million in the prior year.

    • Specialty Products Segment Adjusted EBITDA increased 3% to $41.2 million, as compared to $40.2 million in the prior year.

  • Reconciliation tables for non-GAAP measures are available in the attached schedules.

Fourth Quarter 2025 Results

  • Net sales increased 19% to $102.8 million in the fourth quarter, as compared to $86.2 million in the prior year quarter.

    • Fire Safety net sales decreased 4% to $58.1 million, as compared to $60.7 million in the prior year quarter.

    • Specialty Products net sales increased 75% to $44.7 million, as compared to $25.5 million in the prior year quarter.

  • Net loss during the fourth quarter was $140.2 million, or $0.94 loss per diluted share, as compared to net income of $144.2 million, or $0.90 earnings per diluted share in the prior year quarter.

  • Fourth quarter non-GAAP adjusted earnings per diluted share was $0.13 for both the quarter ended 2025 and 2024.

  • Adjusted EBITDA increased 9% to $36.0 million in the fourth quarter, as compared to $32.9 million in the prior year quarter.

    • Fire Safety Segment Adjusted EBITDA decreased 6% to $25.6 million, as compared to $27.2 million in the prior year quarter.

    • Specialty Products Segment Adjusted EBITDA increased 85% to $10.4 million, as compared to $5.6 million in the prior year quarter.

  • Reconciliation tables for non-GAAP measures are available in the attached schedules.

Capital Allocation

  • The Company invested $7.0 million in capital expenditures for the three months ended December 31, 2025 and $29.6 million for the year ended December 31, 2025.

  • On November 14, 2025, the Company acquired substantially all of the assets and technical data rights of certain electro-optical product lines from a third party, for a total cash purchase price of $40.0 million. The product lines will be included within the Specialty Products Segment.

  • On January 22, 2026, the Company acquired the outstanding capital stock of Medical Manufacturing Technologies, LLC (“MMT”) for a total cash purchase price of $685.0 million which was funded with cash on hand and proceeds from a senior secured notes offering. The Company expects that MMT will be included within its Specialty Products segment.

Conference Call and Webcast

As previously announced, Perimeter Solutions management will hold a conference call at 8:30 a.m. ET on Thursday, February 26, 2026 to discuss financial results for the fourth quarter and full year 2025. The conference call can be accessed by dialing (877) 407-9764 (toll-free) or (201) 689-8551 (toll).

The conference call will also be webcast simultaneously on Perimeter’s website (https://ir.perimeter-solutions.com), accessed under the Investor Relations page. The webcast link will be made available on the Company's website prior to the start of the call; go to the investor relations page of our website to the News & Events menu and click on “Events & Presentations.”

A slide presentation will also be available for reference during the conference call; go to the investor relations page of our website to the News & Events menu and click on “Events & Presentations.”

Following the live webcast, a replay will be available on the Company’s website. A telephonic replay will also be available approximately three hours after the call and can be accessed by dialing (877) 660-6853 (toll-free) or (201) 612-7415 (toll) and using Access ID “13758339”. The telephonic replay will be available until March 26, 2026 (11:59 p.m. ET).

About Perimeter Solutions

Perimeter Solutions (NYSE: PRM) is a leading provider of industrial products and services that support critical and complex customer missions across a range of niche applications. Perimeter’s focus on superior customer service, paired with our Value Driver-focused operating strategy, decentralized operating model, and focus on driving value via capital allocation and capital structure management, fulfills our dual mandate: to serve customers and create value for stockholders. Perimeter is comprised of two segments, Fire Safety, including fire retardants and fire suppressants, and Specialty Products, which currently spans lubricant additives, electronic and electro-mechanical components, and highly engineered machinery for the medical device industry. Perimeter expects to continue expanding its portfolio through organic growth and value creating acquisitions.

Forward-looking Information

This press release may contain “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Forward-looking statements can be identified by words such as: “anticipate,” “intend,” “plan,” “goal,” “seek,” “believe,” “project,” “estimate,” “expect,” “strategy,” “future,” “likely,” “may,” “should,” “will,” and similar references to future periods.

Any such forward-looking statements are not guarantees of performance or results, and involve risks, uncertainties (some of which are beyond the Company’s control) and assumptions. Although Perimeter believes any forward-looking statements are based on reasonable assumptions, you should be aware that many factors could affect the Company’s actual financial results and cause them to differ materially from those anticipated in any forward-looking statements, including the risk factors described from time to time by us in our filings with the Securities and Exchange Commission (“SEC”), including, but not limited to, the Company’s Annual Report on Form 10-K for the year ended December 31, 2025. Stockholders, potential investors and other readers should consider these factors carefully in evaluating the forward-looking statements.

Any forward-looking statement made by Perimeter in this press release speaks only as of the date on which it is made. Perimeter undertakes no obligation to update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.

SOURCE: Perimeter Solutions, Inc.

CONTACT: [email protected]

PERIMETER SOLUTIONS, INC. AND SUBSIDIARIES
Consolidated Statements of Operations and Comprehensive (Loss) Income
(in thousands, except share and per share data)
(Unaudited)

 

 

Three Months Ended December 31,

 

Year Ended December 31,

 

 

 

2025

 

 

 

2024

 

 

 

2025

 

 

 

2024

 

Net sales

 

$

102,750

 

 

$

86,231

 

 

$

652,862

 

 

$

560,968

 

Cost of goods sold

 

 

56,358

 

 

 

44,336

 

 

 

277,712

 

 

 

243,882

 

Gross profit

 

 

46,392

 

 

 

41,895

 

 

 

375,150

 

 

 

317,086

 

Operating expenses (income):

 

 

 

 

 

 

 

 

Selling, general and administrative expense

 

 

21,832

 

 

 

21,013

 

 

 

77,575

 

 

 

66,901

 

Amortization expense

 

 

15,794

 

 

 

13,741

 

 

 

59,696

 

 

 

55,032

 

Founders advisory fees - related party

 

 

171,209

 

 

 

(54,789

)

 

 

435,163

 

 

 

198,308

 

Other operating expense

 

 

2,721

 

 

 

612

 

 

 

3,646

 

 

 

612

 

Total operating expenses (income)

 

 

211,556

 

 

 

(19,423

)

 

 

576,080

 

 

 

320,853

 

Operating (loss) income

 

 

(165,164

)

 

 

61,318

 

 

 

(200,930

)

 

 

(3,767

)

Other expense (income):

 

 

 

 

 

 

 

 

Interest expense, net

 

 

9,691

 

 

 

9,169

 

 

 

39,135

 

 

 

40,461

 

Foreign currency loss (gain)

 

 

211

 

 

 

2,280

 

 

 

(3,038

)

 

 

2,443

 

Other (income) expense, net

 

 

(638

)

 

 

(60

)

 

 

(780

)

 

 

192

 

Total other expense, net

 

 

9,264

 

 

 

11,389

 

 

 

35,317

 

 

 

43,096

 

(Loss) income before income taxes

 

 

(174,428

)

 

 

49,929

 

 

 

(236,247

)

 

 

(46,863

)

Income tax benefit

 

 

34,197

 

 

 

94,241

 

 

 

29,881

 

 

 

40,958

 

Net (loss) income

 

 

(140,231

)

 

 

144,170

 

 

 

(206,366

)

 

 

(5,905

)

Other comprehensive income (loss), net of tax:

 

 

 

 

 

 

 

 

Foreign currency translation adjustments

 

 

3,184

 

 

 

(23,627

)

 

 

32,862

 

 

 

(19,522

)

Total comprehensive (loss) income

 

$

(137,047

)

 

$

120,543

 

 

$

(173,504

)

 

$

(25,427

)

(Loss) earnings per share:

 

 

 

 

 

 

 

 

Basic

 

$

(0.94

)

 

$

0.98

 

 

$

(1.37

)

 

$

(0.04

)

Diluted

 

$

(0.94

)

 

$

0.90

 

 

$

(1.37

)

 

$

(0.04

)

Weighted average number of shares outstanding:

 

 

 

 

 

 

 

 

Basic

 

 

148,808,784

 

 

 

147,058,719

 

 

 

150,370,533

 

 

 

145,713,439

 

Diluted

 

 

148,808,784

 

 

 

160,931,755

 

 

 

150,370,533

 

 

 

145,713,439

 


PERIMETER SOLUTIONS, INC. AND SUBSIDIARIES
Consolidated Balance Sheets
(in thousands, except share data)
(Unaudited)

 

 

December 31, 2025

 

December 31, 2024

ASSETS

 

 

 

 

Current assets:

 

 

 

 

Cash and cash equivalents

 

$

325,927

 

 

$

198,456

 

Accounts receivable, net

 

 

64,363

 

 

 

56,048

 

Inventories

 

 

139,634

 

 

 

116,347

 

Prepaid expenses and other current assets

 

 

34,049

 

 

 

23,173

 

Total current assets

 

 

563,973

 

 

 

394,024

 

Property, plant and equipment, net

 

 

85,138

 

 

 

64,777

 

Operating lease right-of-use assets

 

 

30,152

 

 

 

17,298

 

Finance lease right-of-use assets

 

 

5,713

 

 

 

6,173

 

Goodwill

 

 

1,065,211

 

 

 

1,034,543

 

Customer lists, net

 

 

628,189

 

 

 

637,745

 

Technology and patents, net

 

 

184,804

 

 

 

173,307

 

Tradenames, net

 

 

86,330

 

 

 

87,365

 

Other assets, net

 

 

3,497

 

 

 

1,162

 

Total assets

 

$

2,653,007

 

 

$

2,416,394

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

Current liabilities:

 

 

 

 

Accounts payable

 

$

30,301

 

 

$

23,519

 

Accrued expenses and other current liabilities

 

 

47,212

 

 

 

30,450

 

Founders advisory fees payable – related party

 

 

95,726

 

 

 

6,677

 

Deferred revenue

 

 

1,879

 

 

 

1,842

 

Total current liabilities

 

 

175,118

 

 

 

62,488

 

Long-term debt, net

 

 

669,122

 

 

 

667,774

 

Operating lease liabilities, net of current portion

 

 

27,860

 

 

 

15,540

 

Finance lease liabilities, net of current portion

 

 

5,694

 

 

 

6,013

 

Deferred income taxes

 

 

80,410

 

 

 

152,203

 

Founders advisory fees payable – related party

 

 

440,697

 

 

 

240,083

 

Preferred stock

 

 

115,904

 

 

 

109,966

 

Preferred stock – related party

 

 

1,293

 

 

 

2,831

 

Other non-current liabilities

 

 

3,590

 

 

 

2,226

 

Total liabilities

 

 

1,519,688

 

 

 

1,259,124

 

Commitments and contingencies

 

 

 

 

Stockholders’ equity:

 

 

 

 

Common stock, $0.0001 par value per share, 4,000,000,000 shares authorized; 174,818,216 and 169,426,114 shares issued; 149,440,060 and 147,822,633 shares outstanding at December 31, 2025 and 2024, respectively

 

 

17

 

 

 

17

 

Treasury stock, at cost; 25,378,156 and 21,603,481 shares at December 31, 2025 and 2024, respectively

 

 

(168,197

)

 

 

(127,827

)

Additional paid-in capital

 

 

2,100,958

 

 

 

1,911,035

 

Accumulated other comprehensive loss

 

 

(6,370

)

 

 

(39,232

)

Accumulated deficit

 

 

(793,089

)

 

 

(586,723

)

Total stockholders’ equity

 

 

1,133,319

 

 

 

1,157,270

 

Total liabilities and stockholders’ equity

 

$

2,653,007

 

 

$

2,416,394

 


PERIMETER SOLUTIONS, INC. AND SUBSIDIARIES
Consolidated Statements of Cash Flows
(in thousands)
(Unaudited)

 

 

Year Ended December 31,

 

 

 

2025

 

 

 

2024

 

Cash flows from operating activities:

 

 

 

 

Net loss

 

$

(206,366

)

 

$

(5,905

)

Adjustments to reconcile net loss to net cash provided by operating activities:

 

 

 

 

Founders advisory fees – related party (change in fair value)

 

 

435,163

 

 

 

198,308

 

Depreciation and amortization expense

 

 

74,032

 

 

 

65,718

 

Interest and payment-in-kind on preferred stock

 

 

7,332

 

 

 

7,057

 

Stock-based compensation

 

 

16,647

 

 

 

12,849

 

Non-cash lease expense

 

 

6,861

 

 

 

5,070

 

Deferred income taxes

 

 

(74,144

)

 

 

(99,557

)

Amortization of deferred financing costs

 

 

1,907

 

 

 

1,730

 

Foreign currency (gain) loss

 

 

(3,038

)

 

 

2,443

 

Loss on disposal of assets

 

 

149

 

 

 

66

 

Changes in operating assets and liabilities, net of acquisitions:

 

 

 

 

Accounts receivable

 

 

(6,954

)

 

 

(13,293

)

Inventories

 

 

(5,980

)

 

 

29,872

 

Prepaid expenses and other current assets

 

 

971

 

 

 

(843

)

Accounts payable

 

 

6,228

 

 

 

(754

)

Deferred revenue

 

 

37

 

 

 

1,842

 

Income taxes payable, net

 

 

(5,685

)

 

 

(13,299

)

Accrued expenses and other current liabilities

 

 

4,159

 

 

 

4,306

 

Founders advisory fees – related party (cash settled)

 

 

(6,677

)

 

 

(2,702

)

Operating lease liabilities

 

 

(4,867

)

 

 

(3,278

)

Finance lease liabilities

 

 

(489

)

 

 

(501

)

Other, net

 

 

(1,137

)

 

 

(741

)

Net cash provided by operating activities

 

 

238,149

 

 

 

188,388

 

Cash flows from investing activities:

 

 

 

 

Purchase of property and equipment

 

 

(29,591

)

 

 

(15,531

)

Purchase of intangible assets

 

 

(15,226

)

 

 

 

Proceeds from short-term investments

 

 

 

 

 

5,383

 

Purchase of businesses, net of cash acquired

 

 

(62,000

)

 

 

(32,792

)

Net cash used in investing activities

 

 

(106,817

)

 

 

(42,940

)

Cash flows from financing activities:

 

 

 

 

Common stock repurchased

 

 

(40,370

)

 

 

 

Ordinary shares repurchased

 

 

 

 

 

(14,420

)

Proceeds from exercises of warrants

 

 

 

 

 

23,509

 

Proceeds from exercises of options

 

 

34,453

 

 

 

 

Principal payments on finance lease obligations

 

 

(875

)

 

 

(740

)

Payment for credit facility financing fees

 

 

(2,179

)

 

 

 

Net cash (used in) provided by financing activities

 

 

(8,971

)

 

 

8,349

 

Effect of foreign currency on cash and cash equivalents

 

 

5,110

 

 

 

(2,617

)

Net change in cash and cash equivalents

 

 

127,471

 

 

 

151,180

 

Cash and cash equivalents, beginning of period

 

 

198,456

 

 

 

47,276

 

Cash and cash equivalents, end of period

 

$

325,927

 

 

$

198,456

 

Supplemental disclosures of cash flow information:

 

 

 

 

Cash paid for interest

 

$

36,745

 

 

$

37,317

 

Cash paid for income taxes

 

$

48,851

 

 

$

74,559

 

Non-cash activities:

 

 

 

 

Liability portion of founders advisory fees – related party reclassified to additional paid in capital

 

$

138,823

 

 

$

8,464

 


Non-GAAP Financial Metrics

The Company provides non-GAAP financial measures for Segment Adjusted EBITDA, Adjusted Net Income, and Adjusted Earnings Per Share data as supplemental information regarding the Company’s business performance. The Company believes that these non-GAAP financial measures are useful to investors because they provide investors with a better understanding of the Company’s past financial performance and future results. The Company’s management uses these non-GAAP financial measures when it internally evaluates the performance of its business and makes operating decisions, including internal operating budgeting, performance measurement, and discretionary compensation.

Segment Adjusted EBITDA

Segment Adjusted EBITDA is defined as (loss) income before income taxes plus net interest and other financing expenses, and depreciation and amortization, adjusted on a consistent basis for certain non-recurring, unusual or non-operational items. These items include (i) restructuring, (ii) acquisition related costs, (iii) founder advisory fee expenses, (iv) stock-based compensation expense and (v) foreign currency loss (gain). To supplement the Company’s consolidated financial statements presented in accordance with U.S. GAAP, Perimeter is providing a summary to show the computations of Segment Adjusted EBITDA, which is a non-GAAP measure used by the Company's management and by external users of Perimeter’s financial statements, such as debt and equity investors, commercial banks and others, to assess the Company’s operating performance as compared to that of other companies, without regard to financing methods, capital structure or historical cost basis. Segment Adjusted EBITDA should not be considered an alternative to net (loss) income, operating (loss) income, cash flows provided by operating activities or any other measure of financial performance or liquidity presented in accordance with U.S. GAAP (in thousands).

(Unaudited)

 

Three Months Ended December 31, 2025

 

Three Months Ended December 31, 2024

 

 

Fire Safety

 

Specialty
Products

 

Total

 

Fire Safety

 

Specialty
Products

 

Total

(Loss) income before income taxes

 

$

(152,325

)

 

$

(22,103

)

 

$

(174,428

)

 

$

45,304

 

 

$

4,625

 

 

$

49,929

 

Depreciation and amortization

 

 

14,579

 

 

 

5,843

 

 

 

20,422

 

 

 

12,858

 

 

 

3,645

 

 

 

16,503

 

Interest and financing expense (benefit)

 

 

5,969

 

 

 

3,722

 

 

 

9,691

 

 

 

9,694

 

 

 

(525

)

 

 

9,169

 

Founders advisory fees – related party

 

 

154,106

 

 

 

17,103

 

 

 

171,209

 

 

 

(46,936

)

 

 

(7,853

)

 

 

(54,789

)

Non-recurring expenses (1)

 

 

137

 

 

 

775

 

 

 

912

 

 

 

3,743

 

 

 

626

 

 

 

4,369

 

Acquisition costs

 

 

 

 

 

2,716

 

 

 

2,716

 

 

 

 

 

 

612

 

 

 

612

 

Stock-based compensation expense

 

 

3,390

 

 

 

1,829

 

 

 

5,219

 

 

 

2,735

 

 

 

2,066

 

 

 

4,801

 

Foreign currency (gain) loss

 

 

(323

)

 

 

534

 

 

 

211

 

 

 

(154

)

 

 

2,434

 

 

 

2,280

 

Segment Adjusted EBITDA

 

$

25,533

 

 

$

10,419

 

 

$

35,952

 

 

$

27,244

 

 

$

5,630

 

 

$

32,874

 


(1) For the three months ended December 31, 2025, $0.7 million was related to litigation costs arising from a contractual dispute regarding control of the P2S5 facility, which is currently operated by Flexsys Chemical Company and $0.2 million was related to the redomiciliation of the Company from Luxembourg to Delaware (the “Redomiciliation Transaction”). For the three months ended December 31, 2024, $4.4 million was related to the Redomiciliation Transaction and other non-recurring Luxembourg related costs.


(Unaudited)

 

Year Ended December 31, 2025

 

Year Ended December 31, 2024

 

 

Fire Safety

 

Specialty
Products

 

Total

 

Fire Safety

 

Specialty
Products

 

Total

Loss before income taxes

 

$

(182,537

)

 

$

(53,710

)

 

$

(236,247

)

 

$

(35,277

)

 

$

(11,586

)

 

$

(46,863

)

Depreciation and amortization

 

 

55,397

 

 

 

18,635

 

 

 

74,032

 

 

 

51,365

 

 

 

14,353

 

 

 

65,718

 

Interest and financing expense

 

 

24,059

 

 

 

15,076

 

 

 

39,135

 

 

 

39,547

 

 

 

914

 

 

 

40,461

 

Founders advisory fees – related party

 

 

381,106

 

 

 

54,057

 

 

 

435,163

 

 

 

169,886

 

 

 

28,422

 

 

 

198,308

 

Non-recurring expenses (1)

 

 

955

 

 

 

1,465

 

 

 

2,420

 

 

 

5,559

 

 

 

1,207

 

 

 

6,766

 

Acquisition costs

 

 

98

 

 

 

3,480

 

 

 

3,578

 

 

 

 

 

 

612

 

 

 

612

 

Stock-based compensation expense

 

 

12,207

 

 

 

4,440

 

 

 

16,647

 

 

 

8,545

 

 

 

4,304

 

 

 

12,849

 

Foreign currency (gain) loss

 

 

(798

)

 

 

(2,240

)

 

 

(3,038

)

 

 

496

 

 

 

1,947

 

 

 

2,443

 

Segment Adjusted EBITDA

 

$

290,487

 

 

$

41,203

 

 

$

331,690

 

 

$

240,121

 

 

$

40,173

 

 

$

280,294

 


(1) For the year ended December 31, 2025, $1.1 million was related to restructuring and other non-recurring costs, $0.7 million was related to litigation costs arising from a contractual dispute regarding control of the P2S5 facility, which is currently operated by Flexsys Chemical Company, and $0.6 million was related to the Redomiciliation Transaction. For the year ended December 31, 2024, $6.6 million was related to the Redomiciliation Transaction and other non-recurring Luxembourg related costs and $0.2 million was related to other non-recurring costs.


Adjusted Net Income and Adjusted Earnings Per Share

The computation of Adjusted Earnings Per Share (“Adjusted EPS”) is defined as Adjusted Net Income divided by adjusted diluted shares. Adjusted Net Income is defined as net (loss) income plus amortization, certain non-recurring, unusual or non-operational items, and the tax impact of these non-GAAP adjustments. These adjustments include (i) restructuring, (ii) acquisition related costs, (iii) founder advisory fee expenses, (iv) stock-based compensation expense and (v) foreign currency loss (gain). Adjusted diluted shares is the weighted average diluted shares outstanding, adjusted by adding dilution for options and warrants excluded under U.S. GAAP due to a net loss, less dilution related to founders advisory fees. To supplement the Company’s consolidated financial statements presented in accordance with U.S. GAAP, Perimeter is providing a summary to show the computations of Adjusted Net Income and Adjusted EPS, which are non-GAAP measures used by the Company's management and by external users of Perimeter’s financial statements, such as debt and equity investors, commercial banks and others, to assess the Company's operating performance as compared to that of other companies, without regard to financing methods, capital structure or historical cost basis. Adjusted EPS and Adjusted Net Income should not be considered alternatives to GAAP (loss) earnings per share (“GAAP EPS”), net (loss) income, operating (loss) income, cash flows provided by operating activities or any other measure of financial performance or liquidity presented in accordance with U.S. GAAP (in thousands, except share and per share data).

(Unaudited)

 

Three Months Ended December 31,

 

 

 

2025

 

 

 

2024

 

GAAP net (loss) income

 

$

(140,231

)

 

$

144,170

 

Adjustments:

 

 

 

 

Amortization

 

 

15,794

 

 

 

13,741

 

Founders advisory fees – related party

 

 

171,209

 

 

 

(54,789

)

Non-recurring expenses (1)

 

 

912

 

 

 

4,369

 

Acquisition costs

 

 

2,716

 

 

 

612

 

Stock-based compensation expense

 

 

5,219

 

 

 

4,801

 

Foreign currency loss

 

 

211

 

 

 

2,280

 

Tax impact of non-GAAP adjustments (2)

 

 

(35,937

)

 

 

(96,136

)

Adjusted net income

 

$

19,893

 

 

$

19,048

 

 

 

 

 

 

Shares used in computing GAAP (Loss) Earnings Per Share (diluted)

 

 

148,808,784

 

 

 

160,931,755

 

Options (3)

 

 

7,136,522

 

 

 

 

Shares underlying Founders fixed advisory fees (4)

 

 

 

 

 

(9,428,244

)

Shares underlying Founders variable advisory fees (5)

 

 

 

 

 

 

Shares used in computing Adjusted Earnings Per Share (diluted)

 

 

155,945,306

 

 

 

151,503,511

 

 

 

 

 

 

GAAP (Loss) Earnings Per Share (diluted)

 

$

(0.94

)

 

$

0.90

 

Adjusted Earnings Per Share (diluted)

 

$

0.13

 

 

$

0.13

 

____________________

 

 

 

 

(1) For the three months ended December 31, 2025, $0.7 million was related to litigation costs arising from a contractual dispute regarding control of the P2S5 facility, which is currently operated by Flexsys Chemical Company and $0.2 million was related to the Redomiciliation Transaction. For the three months ended December 31, 2024, $4.4 million was related to the Redomiciliation Transaction and other non-recurring Luxembourg related costs.

(2) The tax impact of non-GAAP adjustments reflects the total income tax expense commensurate with the non-GAAP measure of profitability.

(3) The Company adds back the dilutive impact of options if amounts were excluded for purposes of GAAP EPS due to a GAAP net loss during the period.

(4) As of December 31, 2025, a maximum of 2.4 million shares were issuable within 12 months under the Founders fixed advisory fee. To satisfy the 2025 Founders fixed advisory fee, the Company paid $13.4 million in cash on February 19, 2026 and expects to issue 1.9 million shares of Common Stock in the first quarter of 2026.

(5) Based on period end market prices as of December 31, 2025, a maximum of 14.5 million shares were issuable within 12 months under the Founders variable advisory fee. To satisfy the 2025 Founders variable advisory fee, the Company paid $82.3 million in cash on February 19, 2026 and expects to issue 11.5 million shares of Common Stock in the first quarter of 2026.


(Unaudited)

 

Year Ended December 31,

 

 

 

2025

 

 

 

2024

 

GAAP net loss

 

$

(206,366

)

 

$

(5,905

)

Adjustments:

 

 

 

 

Amortization

 

 

59,696

 

 

 

55,032

 

Founders advisory fees – related party

 

 

435,163

 

 

 

198,308

 

Non-recurring expenses (1)

 

 

2,420

 

 

 

6,766

 

Acquisition costs

 

 

3,578

 

 

 

612

 

Stock-based compensation expense

 

 

16,647

 

 

 

12,849

 

Foreign currency (gain) loss

 

 

(3,038

)

 

 

2,443

 

Tax impact of non-GAAP adjustments (2)

 

 

(101,427

)

 

 

(106,715

)

Adjusted net income

 

$

206,673

 

 

$

163,390

 

 

 

 

 

 

Shares used in computing GAAP (Loss) Earnings Per Share (diluted)

 

 

150,370,533

 

 

 

145,713,439

 

Options (3)

 

 

4,092,617

 

 

 

1,446,487

 

Warrants (3)

 

 

 

 

 

49,876

 

Shares underlying Founders fixed advisory fees (4)

 

 

 

 

 

 

Shares underlying Founders variable advisory fees (5)

 

 

 

 

 

 

Shares used in computing Adjusted Earnings Per Share (diluted)

 

 

154,463,150

 

 

 

147,209,802

 

 

 

 

 

 

GAAP (Loss) Earnings Per Share (diluted)

 

$

(1.37

)

 

$

(0.04

)

Adjusted Earnings Per Share (diluted)

 

$

1.34

 

 

$

1.11

 

____________________

 

 

 

 

(1) For the year ended December 31, 2025, $1.1 million was related to restructuring and other non-recurring costs, $0.7 million was related to litigation costs arising from a contractual dispute regarding control of the P2S5 facility, which is currently operated by Flexsys Chemical Company, and $0.6 million was related to the Redomiciliation Transaction. For the year ended December 31, 2024, $6.6 million was related to the Redomiciliation Transaction and other non-recurring Luxembourg related costs and $0.2 million was related to other non-recurring costs.

(2) The tax impact of non-GAAP adjustments reflects the total income tax expense commensurate with the non-GAAP measure of profitability.

(3) The Company adds back the dilutive impact of options and warrants if amounts were excluded for purposes of GAAP EPS due to GAAP net loss during the period.

(4) As of December 31, 2025, a maximum of 2.4 million shares were issuable within 12 months under the Founders fixed advisory fee. To satisfy the 2025 Founders fixed advisory fee, the Company paid $13.4 million in cash on February 19, 2026 and expects to issue 1.9 million shares of Common Stock in the first quarter of 2026.

(5) Based on period end market prices as of December 31, 2025, a maximum of 14.5 million shares were issuable within 12 months under the Founders variable advisory fee. To satisfy the 2025 Founders variable advisory fee, the Company paid $82.3 million in cash on February 19, 2026 and expects to issue 11.5 million shares of Common Stock in the first quarter of 2026.